Abstract
Xin Shelley Wang, MD, Tong-du Li, MD, Shi-ying Yu, MD, Wei-ping Gu, and Guang-wei Xu, MD Department of Symptom Research (X.S.W.), University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Anhui Cancer Hospital (T.L.), Ben-bu, Anhui Province; Department of Oncology (S.Y.), Tong-ji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei Province; Department of Drug Safety and Inspections (W.G.), State Drug Administration, Beijing; and Chinese Anti-Cancer Association (G.X.), Beijing, P.R. China
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
